Routes of plasmid DNA vaccination that prime murine humoral and cellular immune responses

Vaccine

Volumn 16, Issue 9-10, 1998, Pages 949-954

  Böhm, Waltraud ^a   Mertens, Thomas ^a   Schirmbeck, Reinhold ^a   Reimann, Jörg ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Genetic vaccination; Hepatitis B surface antigen; Routes of vaccination

Indexed keywords

DNA VACCINE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; PLASMID DNA;

ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG EFFECT; FEMALE; HEPATITIS B; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOSTIMULATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINATION;

ANIMALS; ANTIBODY FORMATION; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNITY, CELLULAR; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MICE, INBRED BALB C; PLASMIDS; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, DNA;

EID: 0032077066     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00302-2     Document Type: Article

References (49)

1. 1 Ertl, H.C. and Xiang, Z. Novel vaccine approaches. J. Immunol. 1996, 156, 3579-3582.
2. 2 Hassett, D.E. and Whitton, J.L. DNA immunization. Trends Microbiol. 1996, 4, 307-312.
3. 3 McDonnell, W.M. and Askari, F.K. DNA vaccines. W. Engl. J. Med. 1996, 334, 42-45.
4. 4 Ulmer, J.B., Deck, R.R. and Yawman, A. et al. DNA vaccines for bacteria and viruses. Adv. Exp. Med. Biol. 1996, 397, 49-53.
5. 5 Ulmer, J.B., Sadoff, J.C. and Liu, M.A. DNA vaccines. Curr. Opin. Immunol. 1996, 8, 531-536.
6. 6 Donnelly, J.J., Ulmer, J.B. and Liu, M.A. Immunization with DNA. J. Immunol. Methods 1994, 176, 145-152.
7. 7 An, L.L., Pamer, E.G. and Whitton, J.L. A recombinant minigene vaccine containing a nonameric cytotoxic-T-lymphocyte epitope confers limited protection against Listeria monocytogenes infection. Infect. Immun. 1996, 64, 1685-1693.
8. 8 Bourne, N., Stanberry, L.R., Bernstein, D.I. and Lew, D. DNA immunization against experimental genital herpes simplex virus infection. J. Infect. Dis. 1996, 173, 800-807.
9. 9 Donnelly, J.J., Martinez, D., Jansen, K.U., Ellis, R.W., Montgomery, D.L. and Liu. M.A. Protection against papilloma-virus with a polynucleotide vaccine. J. Infect. Dis. 1996, 713, 314-320.
10. 10 Gonzalez Armas, J.C., Morello, C.S., Cranmer, L.D. and Spector, D.H. DNA immunization confers protection against murine cytomegalovirus infection. J. Virol. 1996, 70, 7921-7928.
11. 11 Herrmann, J.E., Chen, S.C. and Fynan, E.F. et al. Protection against rotavirus infections by DNA vaccination. J. Infect. Dis. 1996, 174, S93-7.
12. 12 Huygen, K., Content, J. and Denis, O. et al. Immunogenicity and protective efficacy of tuberculosis DNA vaccine. Nature Med. 1996, 2, 893-898.
13. 13 Kriesel, J.D., Spruance, S.L., Daynes, R.A. and Araneo, B.A. Nucleic acid vaccine encoding gD2 protects mice from herpes simplex virus type 2 disease. J. Infect. Dis. 1996, 173, 536-541.
14. 14 McClements, W.L., Armstrong, M.E., Keys, R.D. and Liu, M.A. Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease. Proc. Natl Acad. Sci. U S A 1996, 93, 11414-11420.
15. 15 Simon, M.M., Gern, L. and Hauser, P. et al. Protective immunization with plasmid DNA containing the outer surface lipoprotein A gene of Borrelia burgdorferi is independent of an eukaryotic promoter. Eur. J. Immunol. 1996, 26, 2831-2840.
16. 16 Tascon, R.E., Colston, M.J., Ragno, S., Stavropoulos, E., Gregory, D. and Lowrie, D.B. Vaccination against tuberculosis by DNA immunization. Nature Med. 1996, 2, 888-892.
17. 17 Barry, M.A., Lai, W.C. and Johnston, S.A. Protection against mycoplasma infection using expression - library immunization. Nature 1995, 377, 632-635.
18. + T lymphocytes. J. Immunol. 1995, 155, 259-265.
19. 19 Martins, L.P., Lau, L.L., Asano, M.S. and Ahmed, R. DNA vaccination against persistent viral infection. J. Virol. 1995, 69, 2574-2582.
20. 20 Yokoyama, M., Zhang, J. and Whitton, J.L. DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J. Virol. 1995, 69, 2684-2688.
21. 21 Zarozinski, C.C., Fynan, E.F., Selin, L.K., Robinson, H.L. and Welsh, R.M. Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein. J. Immunol. 1995, 154, 4010-4017.
22. 22 Ulmer, J.B., Deck, R.R., DeWitt, C.M., Friedman, A., Donnelly, J.J. and Liu, M.A. Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine 1994, 12, 1541-1544.
23. 23 Xiang, Z.Q., Spitalnik, S., Tran, M., Wunner, W.H., Cheng, J. and Ertl, H.C.J. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 1994, 199, 132-140.
24. 24 Ciernik, I.F., Krayenbuhl, B.H. and Carbone, D.P. Puncture-mediated gene transfer to the skin. Hum. Gene Ther. 1996, 7, 893-899.
25. 25 Raz, E., Tighe, H. and Sato, Y. et al. Preferential induction of a TH1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc. Natl Acad. Sci. USA 1996, 93, 5141-5145.
26. 26 Sato, Y., Roman, M. and Tighe, H. et al. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 1996, 273, 352-354.
27. 27 Raz, E., Carson, D.A. and Parker, S.E. et al. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Natl Acad. Sci. USA 1994, 91, 9519-9523.
28. 28 Tang, D.C., DeVit, M. and Johnston, S.A. Genetic immunization is a simple method for eliciting an immune response. Nature 1992, 356, 152-154.
29. 29 Davis, H.L., Michel, M.L. and Whalen, R.G. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum. Mol. Genet. 1993, 2, 1847-1851.
30. 30 Ulmer, J.B., Donnelly, J.J. and Parker, S.E. et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993, 259, 1745-1749.
31. 31 Wang, B., Ugen, K.E. and Srikantan, V. et al. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl Acad. Sdci. USA 1993, 90, 4156-4160.
32. 32 Wells, D.J. Improved gene transfer by direct plasmid injection associated with regeneration in mouse skeletal muscle. FEBS Lett. 1993, 332, 179-182.
33. 33 Kumar, V. and Sercarz, E. Genetic vaccination: the advantages of going naked. Nature Med. 1996, 2, 857-859.
34. 34 San, H., Yang, Z.Y. and Pompili, V.J. et al. Safety and short-term toxicity of a novel cationic lipid formulation for human gene therapy. Hum. Gene Ther. 1993, 4, 781-788.
35. 35 Haynes, J.R., McCabe, D.E., Swain, W.F., Widera, G. and Fuller, J.T. Particle-mediated nucleic acid immunization. J. Biotechnol. 1996, 44, 37-42.
36. 36 Qiu, P., Ziegelhoffer, P., Sun, J. and Yang, N.S. Gene gun delivery of mRNA in situ results in efficient transgene expression and genetic immunization. Gene Ther. 1996, 3, 262-268.
37. 37 Pertmer, T.M., Eisenbraun, M.D., McCabe, D., Prayaga, S.K., Fuller, D.H. and Haynes, J.R. Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine 1995, 13, 1427-1430.
38. 38 Janowicz, Z.A., Melber, K. and Merckelbach, A. et al. Simultaneous expression of the S and L surface antigens of hepatitis B, and formation of mixed particles in the methylotrophic yeast Hansenula polymorpha. Yeast 1991, 7, 431-443.
39. 39 Diminsky, D., Schirmbeck, R., Reimann, J. and Barenholz, Y. Comparison between surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast cells (Hansenula polymorpha): composition, structure and immunogenicity. Vaccine 1997, 15, 637-647.
40. 40 Schirmbeck, R., Melber, K., Mertens, T. and Reimann, J. Selective stimulation of murine cytotoxic T cell and antibody responses by particulate or monomeric hepatitis B virus surface (S) antigen. Eur. J. Immunol. 1994, 24, 1088-1096.
41. 41 Schirmbeck, R., Melber, K., Kuhröber, A., Janowicz, Z.A. and Reimann, J. Immunization with soluble hepatitis B virus surface (S) protein particles elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo. J. Immunol. 1994, 152, 1110-1119.
42. 42 Davis, H.L., Whalen, R.G. and Demeneix, B.A. Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression. Hum. Gene Ther. 1993, 4, 151-159.
43. 43 Davis, H.L., Schirmbeck, R., Reimann, J. and Whalen, R.G. DMA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to Hepatitis B virus surface antigen. Hum. Gene Ther. 1995, 6, 1447-1456.
44. 44 Schirmbeck, R., Böhm, W. and Reimann, J. Virus-like particles induce MHC class I-restricted T cell responses: lessons learned from Hepatitis B virus surface antigen. Intervirology 1996, 39, 111-119.
45. 45 Corr, M., Lee, D.J., Carson, D.A. and Tighe, H. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med. 1996, 184, 1555-1560.
46. 46 Doe, B., Selby, M., Barnett, S., Baenziger, J. and Walker, C.M. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc. Natl Acad. Sci. USA 1996, 93, 8578-8583.
47. 47 Ulmer, J.B., Deck, R.R., DeWitt, C.M., Donnhly, J.I. and Liu, M.A. Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells. Immunology 1996, 89, 59-67.
48. d-restricted epitope presentation depends on exogenous b2m. Eur. J. Immunol., in press.
49. 49 Schirmbeck, R., Melber, K. and Reimann, J. Hepatitis B virus surface particles are processed in a novel endosomal pathway for MHC class I-restricted epitope presentation. Eur. J. Immunol. 1995, 25, 1063-1070.